Gyula Domján

805 total citations
42 papers, 611 citations indexed

About

Gyula Domján is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Gyula Domján has authored 42 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Gyula Domján's work include Multiple Myeloma Research and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). Gyula Domján is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). Gyula Domján collaborates with scholars based in Hungary, United States and Antigua and Barbuda. Gyula Domján's co-authors include Klára Gadó, András Falus, Hargita Hegyesi, Akos Szakmary, Rainer de Martin, Siegfried Knasmüller, Dénes Bánhegyi, István Vályi‐Nagy, Géza Sas and G Blaskó and has published in prestigious journals such as Clinica Chimica Acta, Thrombosis and Haemostasis and Journal of Thrombosis and Haemostasis.

In The Last Decade

Gyula Domján

39 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gyula Domján Hungary 12 217 176 139 113 71 42 611
Abbas Raza United States 13 265 1.2× 89 0.5× 254 1.8× 93 0.8× 55 0.8× 49 647
R. Pescador Italy 14 191 0.9× 40 0.2× 167 1.2× 71 0.6× 23 0.3× 56 654
D. Chimenti Italy 16 44 0.2× 243 1.4× 230 1.7× 71 0.6× 34 0.5× 24 816
Marta Centra Italy 13 66 0.3× 58 0.3× 317 2.3× 36 0.3× 77 1.1× 16 617
Daisuke Shima Japan 14 95 0.4× 36 0.2× 270 1.9× 72 0.6× 37 0.5× 27 589
E. Rogier France 14 53 0.2× 195 1.1× 250 1.8× 112 1.0× 26 0.4× 23 774
Sven-Åge Killmann Denmark 16 288 1.3× 173 1.0× 145 1.0× 136 1.2× 108 1.5× 37 811
Yuji Hitomi Japan 8 80 0.4× 117 0.7× 164 1.2× 49 0.4× 70 1.0× 15 550
Shujuan Huang China 14 213 1.0× 73 0.4× 315 2.3× 116 1.0× 48 0.7× 35 699
Dianne E. van der Wal Australia 11 461 2.1× 92 0.5× 108 0.8× 38 0.3× 49 0.7× 22 680

Countries citing papers authored by Gyula Domján

Since Specialization
Citations

This map shows the geographic impact of Gyula Domján's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gyula Domján with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gyula Domján more than expected).

Fields of papers citing papers by Gyula Domján

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gyula Domján. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gyula Domján. The network helps show where Gyula Domján may publish in the future.

Co-authorship network of co-authors of Gyula Domján

This figure shows the co-authorship network connecting the top 25 collaborators of Gyula Domján. A scholar is included among the top collaborators of Gyula Domján based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gyula Domján. Gyula Domján is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovács, Zsuzsanna, et al.. (2018). Hogyan előzzük meg a gyermekbántalmazást? A prevenciós munka jelentősége és kihívásai. 59(5). 63–69. 1 indexed citations
2.
Kovács, Zsuzsanna, et al.. (2018). A gyermekbántalmazás és elhanyagolás primer prevenciós vonatkozásai. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 62(1-2). 39–57. 2 indexed citations
3.
Tóth, Gábor, et al.. (2015). Bilateraler simultaner retinaler Zentralvenenverschluss bei Protein-S-Mangel. Der Ophthalmologe. 112(11). 929–931. 4 indexed citations
4.
Sinkovits, György, Péter Farkas, Dorottya Csuka, et al.. (2014). Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura. Thrombosis Research. 133(4). 616–621. 15 indexed citations
5.
Gadó, Klára & Gyula Domján. (2014). Thrombocytopenia. Orvosi Hetilap. 155(8). 291–303. 5 indexed citations
6.
Réti, Marienn, Péter Farkas, Dorottya Csuka, et al.. (2012). Complement activation in thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 10(5). 791–798. 105 indexed citations
7.
Gadó, Klára & Gyula Domján. (2012). Thromboembolic events in malignant disorders. Orvosi Hetilap. 153(24). 934–947. 2 indexed citations
8.
Mikala, Gábor, Attila Juhász, Attila Tordai, et al.. (2006). Detection of four lymphotropic herpesviruses in Hungarian Patients with multiple myeloma and lymphoma. FEMS Immunology & Medical Microbiology. 49(1). 62–67. 8 indexed citations
9.
Jakab, Katalin, et al.. (2005). Application of flow cytometry immunophenotyping and multidrug resistance assay in B-cell acute lymphoid leukemia and multiple myeloma.. PubMed. 52(1). 36–42. 4 indexed citations
10.
Gadó, Klára, Éva Pállinger, Péter Kovács, et al.. (2002). Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunology Letters. 82(3). 191–196. 17 indexed citations
11.
Gadó, Klára, et al.. (2002). Functional significance of genetic abnormalities in multiple myeloma. PubMed. 32(3). 191–208. 3 indexed citations
12.
Gadó, Klára, Gábor Gigler, Béla Tóth, et al.. (2001). Elevated Levels of Serum Prolactin in Patients with Advanced Multiple Myeloma. NeuroImmunoModulation. 9(4). 231–236. 11 indexed citations
13.
Gadó, Klára, et al.. (2001). Evidence of Prolactin Immunoreactivity in the Bone Marrow of Untreated Multiple Myeloma Patients. NeuroImmunoModulation. 9(2). 95–102. 9 indexed citations
14.
Gadó, Klára, Gyula Domján, Hargita Hegyesi, & András Falus. (2000). ROLE OF INTERLEUKIN‐6 IN THE PATHOGENESIS OF MULTIPLE MYELOMA. Cell Biology International. 24(4). 195–209. 123 indexed citations
15.
Berencsi, György, et al.. (1999). Human Herpesvirus 8 in Hematologic Diseases. Pathology & Oncology Research. 5(1). 73–79. 15 indexed citations
16.
Vályi‐Nagy, István, et al.. (1997). Application of near infrared spectroscopy to the determination of haemoglobin. Clinica Chimica Acta. 264(1). 117–125. 16 indexed citations
17.
Knasmüller, Siegfried, Rainer de Martin, Gyula Domján, & Akos Szakmary. (1989). Studies on the antimutagenic activities of garlic extract. Environmental and Molecular Mutagenesis. 13(4). 357–365. 55 indexed citations
18.
Gruber, András, et al.. (1986). [Hemorrhagic tissue necrosis and functional protein C deficiency in monoclonal gammopathy].. PubMed. 127(21). 1257–60. 1 indexed citations
19.
Fazekas, Á & Gyula Domján. (1962). Biochemical examination of the effect of cortizol on gluconeogenesis.. PubMed. 24. 267–74. 1 indexed citations
20.
Domján, Gyula, et al.. (1962). Biochemical studies on phosphomonoesterases of cirrhotic rat-liver after partial hepatectomy.. PubMed. 24. 129–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026